Alzchem Group AG (ACT.DE) Thursday said that its consolidated result improved in the third quarter, helped by good performance by the Specialty Chemicals segment. Sales rose 6 percent from a year ago and the company also reaffirmed its outlook for full-year 2025.
The German specialty chemicals company reported consolidated result attributable to shareholders of 16.29 million euros, or 1.61 euros per share, in the third quarter, higher than 12.38 million euros or 1.22 euros per share in the year-ago period.
During the three-month period, sales climbed 6 percent to 137.27 million euros from 128.94 million euros in the same period last year, helped by a 9 percent growth in the sales of Specialty Chemicals segment.
Third-quarter EBITDA came in at 29.72 million euros, higher than 24.88 million euros recorded in the corresponding period of fiscal 2024. The EBITDA margin for the period rose to 21.7 percent from 19.3 percent in the prior-year period.
Looking ahead, the company said that its Management Board has reaffirmed its fiscal 2025 outlook of sales growth to around 580 million euros and an EBITDA increase to around 113 million euros.
On the XETRA Exchange, ACT.DE ended Wednesday's trading at 149.20 euros, down 3.24 percent.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.